Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma

Small cell variant of mantle cell lymphoma is an indolent lymphoma characterized by bone marrow involvement, splenomegaly, and a low Ki-67 index

(2011) Yoshizo Kimura et al.   CANCER SCIENCE

Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis

(2011) S. L. Ondrejka et al.   HAEMATOLOGICA

Indolent Mantle-Cell Lymphoma: Immunoglobulin Variable Region Heavy Chain Sequence Analysis Reveals Evidence of Disease 10 Years Prior to Symptomatic Clinical Presentation

(2011) Simon A.J. Rule et al.   JOURNAL OF CLINICAL ONCOLOGY

Impact of TP53 mutation and 17p deletion in mantle cell lymphoma

(2011) A M Halldórsdóttir et al.   LEUKEMIA

The complex landscape of genetic alterations in mantle cell lymphoma

(2011) Cristina Royo et al.   SEMINARS IN CANCER BIOLOGY

Molecular Pathogenesis of Mantle Cell Lymphoma: New Perspectives and Challenges With Clinical Implications

(2011) Alba Navarro et al.   SEMINARS IN HEMATOLOGY

Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era

(2010) P. Perez-Galan et al.   BLOOD

Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma

(2010) V. Fernandez et al.   CANCER RESEARCH

SOX4 overexpression regulates the p53-mediated apoptosis in hepatocellular carcinoma: clinical implication and functional analysis in vitro

(2010) Wonhee Hur et al.   CARCINOGENESIS

Organogenesis relies on SoxC transcription factors for the survival of neural and mesenchymal progenitors

(2010) Pallavi Bhattaram et al.   Nature Communications

Ubiquitin-independent p53 proteasomal degradation

(2009) P Tsvetkov et al.   CELL DEATH AND DIFFERENTIATION

Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma

(2009) M. Dictor et al.   HAEMATOLOGICA

SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype

(2009) A. Mozos et al.   HAEMATOLOGICA

Time to Treatment Does Not Influence Overall Survival in Newly Diagnosed Mantle-Cell Lymphoma

(2009) Heather E. Eve et al.   JOURNAL OF CLINICAL ONCOLOGY

Outcome of Deferred Initial Therapy in Mantle-Cell Lymphoma

(2009) Peter Martin et al.   JOURNAL OF CLINICAL ONCOLOGY

Induction of SOX4 by DNA damage is critical for p53 stabilization and function

(2009) X. Pan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies

(2008) P. Martin et al.   ANNALS OF ONCOLOGY

Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas

(2008) I. Wlodarska et al.   BLOOD

Delineation of distinct tumour profiles in mantle cell lymphoma by detailed cytogenetic, interphase genetic and morphological analysis

(2008) Tiemo Katzenberger et al.   BRITISH JOURNAL OF HAEMATOLOGY

The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival

(2008) Xiao Wang et al.   BRITISH JOURNAL OF HAEMATOLOGY

The three SoxC proteins—Sox4, Sox11 and Sox12—exhibit overlapping expression patterns and molecular properties

(2008) Peter Dy et al.   NUCLEIC ACIDS RESEARCH

Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma

(2007) S. Ek et al.   BLOOD

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

(2007) E. Hoster et al.   BLOOD